In March 2026, the Federal Commission on Addiction and the Prevention of Noncommunicable Diseases declared the previous Swiss guidelines for low-risk alcohol consumption invalid and explicitly stated that the widespread assumption that a glass of wine is good for the heart is not true. This brings a topic back into the clinical setting that had long been considered settled. The current evidence paints a nuanced picture: For atrial fibrillation and hypertension, alcohol is an early-onset, dose-dependent, and—above all—modifiable risk factor, for which randomized intervention data are now available. For coronary heart disease, the evidence remains less certain than the “red wine narrative” would ever have allowed.
Related Topics
You May Also Like
- From symptom to diagnosis
Intrapelvic mass with an ambiguous differential diagnosis
- Endocrinology: APECED-Associated Hypoparathyroidism
A parathyroid hormone analog corrected serum calcium levels
- Transient ischemic attack
Comprehensive diagnostic testing can reduce the risk of stroke
- Malignant Tumors of the Clavicle
Surgical Challenges and Recurrence Patterns
- Chronic hand eczema: common, long-lasting, and distressing
Non-steroidal anti-inflammatory treatment options are essential for long-term management
- Alcohol Consumption While Taking Semaglutide
Withdrawal Symptoms Thanks to GLP-1 RA?
- Why Echocardiography Has Redefined the Clinical Picture
Rheumatic Heart Disease in Children and Adolescents
- Non-anginal chest pain: Could it be a heart attack?